Business Wire

ASC24

7.2.2024 10:31:30 CET | Business Wire | Press release

Share
ASC24 Student Supercomputer Challenge: Twenty-five University Teams Worldwide Advance to the Finals

The preliminary results for the 2024 ASC Student Supercomputer Challenge (ASC24) have been announced. Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals. Among the finalists are renowned institutions such as Huazhong University of Science and Technology, Peking University, the Chinese University of Hong Kong, National Tsing Hua University, Friedrich-Alexander-University Erlangen-Nuremberg, and the National University of Cordoba. They will compete for prestigious awards including the Champion, Silver Prize, Group Competition Award, e Prize, and Highest LINPACK at the finals hosted by Shanghai University from April 9 to 13, 2024.

In response to the challenge posed by a large number of excellent teams, the ASC Organizing Committee, and Shanghai University have decided to accommodate 25 teams for the ASC24 Finals, setting a new record for the highest number of teams qualified for onsite finals since the inception of the ASC competition in 2012.

Among the finalists, Huazhong University of Science and Technology's team demonstrated an in-depth grasp of supercomputing knowledge and technologies. Through precise performance bottleneck analysis and innovative optimization methods, they achieved outstanding results. Their exceptional performance across all tasks secured them the top rank in the preliminary round.

The ASC24 finals feature a lineup of traditional powerhouses, including Peking University - the champion of the 10th ASC onsite finals; the Chinese University of Hong Kong - the champion of the 10th ASC virtual finals; University of Science and Technology of China; Shanghai Jiao Tong University; and Friedrich-Alexander-University Erlangen-Nuremberg. Additionally, there is great excitement surrounding the debut of teams from National University of Cordoba, Macau University of Science and Technology, and Southwest Petroleum University, marking their first appearance in the ASC finals this year.

The ASC24 preliminaries included two computational tasks: Large Language Model (LLM) Inference Optimization and Seepage Numerical Simulation. Numerous participating teams excelled, showcasing remarkable capabilities in exploring and innovating in supercomputing application analysis, performance optimization, and parallel strategy design.

In the Large Language Model (LLM) Inference Optimization Challenge, participating teams were assigned the task of building and refining inference engines using the widely used open-source LLM, LLaMA2. The main goal was to achieve high-throughput inference on sample datasets provided by the organizing committee. Teams contending for success were expected to showcase a thorough understanding and proficiency in common parallel methods applicable to LLMs. Furthermore, they were tasked with implementing various techniques to enhance the inference process.

The team from Huazhong University of Science and Technology developed an LLM inference engine that incorporated tensor parallelism, KVCache, and PagedAttention. Additionally, they implemented asynchronous pipelining in parallel to address the issue of incomplete loading of model parameters on a single server. Moreover, they deployed a distributed memory manager on each node to ensure load balancing and conducted numerous comparative experiments to identify the optimal optimization method. These efforts propelled them to achieve the highest score. On the other hand, the team from Friedrich-Alexander-University Erlangen-Nuremberg utilized a customized TensorRT-LLM engine for their cluster. Through various experiments, they determined that a batch size of 8 resulted in twice the throughput compared to a batch size of 1. By leveraging tensor parallelism and batched generation, they achieved good performance.

The Seepage Simulation Task in ASC24 was designed to delve into the intricate flow patterns and characteristics of multiphase fluids within porous media using the open-source software OpenCAEPoro. Participating teams were tasked with simulating the seepage of multiphase fluids, including oil, gas, and water, specifically in scenarios related to petroleum extraction, based on the dataset provided by the organizing committee. The challenge required teams to skillfully optimize large-scale parallel computing processes, with a focus on improving the computing performance and parallel efficiency of discrete algorithms.

The team from Qinghai University utilized common optimization methods, including function inlining, loop expansion, and operator fusion, after conducting a detailed analysis of the seepage simulation software OpenCAEPoro. They also implemented vectorization and memory access optimization to address computational bottleneck matrix assembly, resulting in highly effective optimization. Meanwhile, the National Tsing Hua University team conducted a comprehensive analysis of OpenCAEPoro, pinpointing the primary bottleneck for CPU parallelization. They leveraged optimized compiler flags and computing libraries to achieve the best performance.

About ASC

The ASC Student Supercomputer Challenge is the world's largest student supercomputer competition, sponsored and organized by the Asia Supercomputer Community with support from experts and institutions across Asia, Europe, and America. The main objectives of ASC are to encourage the exchange and training of young supercomputing talent from different countries, improve supercomputing applications and R&D capacity, boost the development of supercomputing, and promote technical and industrial innovation. The first ASC Student Supercomputer Challenge was held in 2012 and has since attracted over 10,000 undergraduates from all over the world. Learn more for ASC at http://www.asc-events.net/StudentChallenge/index.html.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240207108190/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing5.2.2026 07:30:00 CET | Press release

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato-ku, Tokyo; Chairman, President and Group CEO: Shigekazu Takeuchi) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano, “Sysmex”) have agreed on a sales collaboration for dementia testing. This agreement follows continued discussions based on the Basic Agreement on Business Collaboration in the Field of Immunoassay concluded in October 2023.1 Sysmex will exclusively sell Fujirebio's fully automated Lumipulse® immunoassay systems and dementia-related reagents ("the Products") in regions and countries mutually agreed upon by both companies. Going forward, Fujirebio and Sysmex will collaborate to meet the growing testing needs accompanying the wider adoption of therapeutic drugs and will gradually expand the countries where the Products are sold. Since entering into the Basic Agreement on Business Collaboration in Octob

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide5.2.2026 06:30:00 CET | Press release

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat®KMT2A + MRD Assay and Software to its industry-leading oncology portfolio. The assay leverages digital PCR (dPCR) to support both screening and precise longitudinal MRD monitoring for KMT2A rearrangements in acute myeloid leukemia (AML) subjects. This quantitative test is currently available for research use in clinical trials and as a stand-alone kit for purchase by our global customers, and will soon be available as a service in our regional LabPMM® laboratories worldwide. The assay is available to detect key AML-associated KMT2A rearrangements, which account for the vast majority of KMT2A fusion partners in AML1 and those most commonly targeted in menin-inhibitor clinical development programs. Later this year, the assay will be enhanced with four additional KMT2A rearrangements which are frequently found in acute lymphocytic leukemia (ALL), expan

VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 01:00:00 CET | Press release

Enabling Next-Generation High-Performance Automotive Camera Systems VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise

Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 22:30:00 CET | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 22:30:00 CET | Press release

Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye